{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:04:42Z","timestamp":1775822682038,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:00:00Z","timestamp":1746316800000},"content-version":"vor","delay-in-days":123,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022218","name":"Fiona Wood Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008440","name":"International Parkinson and Movement Disorder Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.prdoa.2025.100340","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:55:17Z","timestamp":1746500117000},"page":"100340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An unusual presentation of Huntington\u2019s disease-like syndrome in a patient with Xeroderma pigmentosum type F: Case report and review of the literature"],"prefix":"10.1016","volume":"12","author":[{"given":"Nicolas","family":"De Cleene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clancy","family":"Cerejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Peball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Stanzial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Benedicenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renate","family":"Lunzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Seppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Heim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prdoa.2025.100340_b0005","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2022-2-5","article-title":"Xeroderma pigmentosum: an updated review","volume":"11","author":"Leung","year":"2022","journal-title":"Drugs Context"},{"issue":"3 Pt 2","key":"10.1016\/j.prdoa.2025.100340_b0010","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/jid.2011.426","article-title":"Shining a light on xeroderma pigmentosum","volume":"132","author":"DiGiovanna","year":"2012","journal-title":"J. Invest. Dermatol."},{"issue":"9","key":"10.1016\/j.prdoa.2025.100340_b0015","doi-asserted-by":"crossref","first-page":"E1236","DOI":"10.1073\/pnas.1519444113","article-title":"Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect","volume":"113","author":"Fassihi","year":"2016","journal-title":"PNAS"},{"issue":"1 Suppl","key":"10.1016\/j.prdoa.2025.100340_b0020","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1590\/S1415-47572014000200008","article-title":"DNA repair diseases: what do they tell us about cancer and aging?","volume":"37","author":"Menck","year":"2014","journal-title":"Genet. Mol. Biol."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100340_b0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/jmg.2010.083022","article-title":"Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair","volume":"48","author":"Bradford","year":"2011","journal-title":"J. Med. Genet."},{"issue":"17","key":"10.1016\/j.prdoa.2025.100340_b0030","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1073\/pnas.94.17.9463","article-title":"In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients","volume":"94","author":"Reardon","year":"1997","journal-title":"PNAS"},{"issue":"22","key":"10.1016\/j.prdoa.2025.100340_b0035","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1111\/bph.14557","article-title":"Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms","volume":"176","author":"Abeti","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.prdoa.2025.100340_b0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2017.03.021","article-title":"Xeroderma pigmentosum complementation group F: a rare cause of cerebellar ataxia with chorea","volume":"376","author":"Carr\u00e9","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100340_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.1993.tb00154.x","article-title":"A case of xeroderma pigmentosum complementation group F with neurological abnormalities","volume":"128","author":"Moriwaki","year":"1993","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100340_b0050","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1523-1747.1998.00171.x","article-title":"Homozygous R788W point mutation in the XPF gene of a patient with xeroderma pigmentosum and late-onset neurologic disease","volume":"110","author":"Sijbers","year":"1998","journal-title":"J, Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.prdoa.2025.100340_b0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neurol.2011.02.039","article-title":"Xeroderma pigmentosum: a rare cause of chorea","volume":"167","author":"Adamec","year":"2011","journal-title":"Revue Neurologique"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100340_b0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000362115","article-title":"Xeroderma pigmentosum\/de sanctis-cacchione syndrome: unusual cause of ataxia","volume":"6","author":"Fekete","year":"2014","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.prdoa.2025.100340_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1107460","article-title":"Case report: variants in the ERCC4 gene as a rare cause of cerebellar ataxia with chorea","volume":"14","author":"Kulikowska","year":"2023","journal-title":"Front. Genet."},{"issue":"8","key":"10.1016\/j.prdoa.2025.100340_b0070","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/mds.29071","article-title":"Adult-onset neurodegeneration in nucleotide excision repair disorders (NERDND): time to move beyond the skin","volume":"37","author":"Cordts","year":"2022","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.prdoa.2025.100340_b0075","first-page":"e240","article-title":"Neurodegeneration as the presenting symptom in 2 adults with xeroderma pigmentosum complementation group F. Neurology","volume":"4","author":"Shanbhag","year":"2018","journal-title":"Genetics"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100340_b0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/acn3.511","article-title":"Xeroderma pigmentosum is a definite cause of Huntington's disease-like syndrome","volume":"5","author":"Garcia-Moreno","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"14","key":"10.1016\/j.prdoa.2025.100340_b0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1212\/WNL.0000000000201065","article-title":"Clinical reasoning: a 60-year-old man with ataxia, chorea, and mild cognitive impairment","volume":"99","author":"Sugiyama","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.prdoa.2025.100340_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s10038-017-0408-5","article-title":"Cerebellar ataxia-dominant phenotype in patients with ERCC4 mutations","volume":"63","author":"Doi","year":"2018","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.prdoa.2025.100340_b0095","unstructured":"K.N. Jocson, D. Togasaki, B. Fogel. Chorea and ataxia as manifestations of Xeroderma Pigmentosum: a case report [abstract]. Mov. Disord. 33 (suppl 2) 2018. https:\/\/www.mdsabstracts.org\/abstract\/chorea-and-ataxia-as-manifestations-of-xeroderma-pigmentosum-a-case-report\/. Accessed August 31, 2023."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100340_b0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(74)90057-4","article-title":"Neurological manifestations of xeroderma pigmentosum in two siblings","volume":"22","author":"Thrush","year":"1974","journal-title":"J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100340_b0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00403-011-1190-4","article-title":"Severe phenotypes in two Tunisian families with novel XPA mutations: evidence for a correlation between mutation location and disease severity","volume":"304","author":"Messaoud","year":"2012","journal-title":"Arch. Dermatol. Res."},{"issue":"Pt 8","key":"10.1016\/j.prdoa.2025.100340_b0110","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/brain\/awn126","article-title":"Neurological symptoms and natural course of xeroderma pigmentosum","volume":"131","author":"Anttinen","year":"2008","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100340_b0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12311-024-01755-1","article-title":"Beyond Huntington's disease - late-onset chorea caused by a homozygous variant in ERCC4","volume":"24","author":"Barthel","year":"2024","journal-title":"Cerebellum (London, England)"},{"issue":"2","key":"10.1016\/j.prdoa.2025.100340_b0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2015.06.026","article-title":"The ERCC1 and ERCC4 (XPF) genes and gene products","volume":"569","author":"Manandhar","year":"2015","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.prdoa.2025.100340_b0125","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajhg.2013.04.007","article-title":"Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia","volume":"92","author":"Kashiyama","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"27","key":"10.1016\/j.prdoa.2025.100340_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217423120","article-title":"Deep intronic founder mutations identified in the ERCC4\/XPF gene are potential therapeutic targets for a high-frequency form of xeroderma pigmentosum","volume":"120","author":"Senju","year":"2023","journal-title":"PNAS"},{"key":"10.1016\/j.prdoa.2025.100340_b0135","first-page":"12","article-title":"Selective neuronal vulnerability to oxidative stress in the brain","volume":"2","author":"Wang","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.prdoa.2025.100340_b0140","unstructured":"R. Lucero, D. Horowitz D. StatPearls. StatPearls Publishing; [Accessed 31 August 2023]. Xeroderma pigmentosum. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551563\/."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100340_b0145","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.2353\/ajpath.2009.090351","article-title":"Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice","volume":"175","author":"Zattra","year":"2009","journal-title":"Am J Pathol."},{"issue":"6","key":"10.1016\/j.prdoa.2025.100340_b0150","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4103\/ijd.ijd_329_21","article-title":"Current Therapeutic Strategies of Xeroderma Pigmentosum","volume":"66","author":"Hossain","year":"2021","journal-title":"Indian J. Dermatol."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:22:15Z","timestamp":1775820135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112525000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":30,"alternative-id":["S2590112525000441"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100340","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An unusual presentation of Huntington\u2019s disease-like syndrome in a patient with Xeroderma pigmentosum type F: Case report and review of the literature","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100340"}}